Eunhee Kim Selected Research

Retinal Degeneration

1/2020	PARP1 Impedes SIRT1-Mediated Autophagy during Degeneration of the Retinal Pigment Epithelium under Oxidative Stress.
1/2019	Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eunhee Kim Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 06/2003
16	Stroke (Strokes) 01/2022 - 04/2008
12	Parkinson Disease (Parkinson's Disease) 02/2024 - 11/2009
7	Necrosis 02/2024 - 01/2013
7	Infarction (Infarctions) 01/2022 - 01/2007
7	Ischemia 10/2018 - 02/2004
6	Human Influenza (Influenza) 02/2023 - 01/2011
5	Infections 09/2023 - 12/2010
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 05/2015
5	Leukemia 09/2016 - 06/2013
4	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 12/2005
4	Inflammation (Inflammations) 09/2023 - 12/2010
4	Brain Injuries (Brain Injury) 01/2023 - 02/2007
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 05/2015
4	Ischemic Stroke 01/2020 - 02/2007
4	Glioma (Gliomas) 01/2020 - 05/2009
4	Hypoxia (Hypoxemia) 10/2017 - 02/2004
3	Brain Ischemia (Cerebral Ischemia) 01/2023 - 02/2007
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
3	Breast Neoplasms (Breast Cancer) 06/2018 - 01/2017
2	Melanoma (Melanoma, Malignant) 03/2023 - 05/2014
2	Common Cold 02/2023 - 09/2020
2	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 10/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 01/2022
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 12/2010
2	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 01/2019
2	Retinal Degeneration 01/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2006
2	Neuroblastoma 09/2019 - 01/2016
2	Cerebral Infarction 10/2018 - 02/2007
2	RNA Virus Infections 01/2018 - 05/2017
2	Adenoma (Adenomas) 12/2017 - 04/2004
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 08/2017 - 01/2017
2	Anemia 01/2009 - 02/2007
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2005 - 04/2004
1	Brain Abscess (Abscess, Brain) 11/2023
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2023
1	Brain Diseases (Brain Disorder) 09/2023
1	Influenza in Birds (Avian Flu) 02/2023
1	Carcinoma (Carcinomatosis) 01/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2006
6	CytokinesIBA 11/2021 - 04/2008
6	Messenger RNA (mRNA)IBA 01/2020 - 04/2004
5	LigandsIBA 03/2023 - 02/2007
4	Amyloid (Amyloid Fibrils)IBA 11/2023 - 07/2018
4	Peptides (Polypeptides)IBA 09/2023 - 10/2006
4	EnzymesIBA 03/2023 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
4	RNA Splicing FactorsIBA 01/2022 - 01/2016
3	Antiviral Agents (Antivirals)IBA 02/2023 - 05/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2014
3	SynucleinsIBA 01/2022 - 01/2016
3	Bevacizumab (Avastin)FDA Link 01/2021 - 05/2015
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	Neuraminidase (Sialidase)IBA 01/2020 - 01/2011
3	Retinaldehyde (Retinal)IBA 01/2019 - 01/2013
3	Protein Kinases (Protein Kinase)IBA 01/2019 - 10/2017
3	Contrast MediaIBA 06/2016 - 05/2009
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016 - 05/2014
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2014 - 04/2008
2	Death Domain ReceptorsIBA 02/2024 - 01/2022
2	KM-819IBA 02/2024 - 01/2022
2	lactate 2-monooxygenaseIBA 03/2023 - 01/2023
2	Lactic Acid (Lactate)FDA LinkGeneric 03/2023 - 01/2023
2	kumi-kyokatsu-toIBA 02/2023 - 09/2020
2	pembrolizumabIBA 01/2023 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2014
2	CorticosteroneIBA 01/2022 - 01/2019
2	Interleukin-3 (Interleukin 3)IBA 01/2021 - 06/2013
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 09/2019
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2018 - 01/2016
2	Interferon Type IIBA 01/2018 - 05/2017
2	Oxygen (Dioxygen)IBA 10/2017 - 01/2017
2	Lysine (L-Lysine)FDA Link 01/2017 - 04/2016
2	AntioxidantsIBA 08/2016 - 02/2007
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 12/2006
2	CholesterolIBA 11/2015 - 11/2006
2	Apolipoproteins E (ApoE)IBA 11/2015 - 04/2008
2	VemurafenibIBA 10/2015 - 05/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 08/2012
2	Oseltamivir (Tamiflu)FDA Link 06/2012 - 01/2011
2	4,4',5'-trimethylazapsoralenIBA 01/2009 - 09/2006
2	Adenosine Diphosphate (ADP)IBA 01/2005 - 10/2003
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2005 - 04/2004
2	BuffersIBA 12/2004 - 02/2004
1	Valosin Containing ProteinIBA 01/2024
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	SaltsIBA 09/2023
1	SpyTag peptideIBA 03/2023
1	LactatesIBA 03/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2023
1	CatalaseIBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023

Therapy/Procedure

21	Therapeutics 01/2024 - 06/2003
2	Neoadjuvant Therapy 06/2018 - 01/2017
2	Aftercare (After-Treatment) 10/2015 - 03/2010
1	Ligation 03/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2023